UiPath (NYSE:PATH) Upgraded at Zacks Research

Zacks Research upgraded shares of UiPath (NYSE:PATHFree Report) from a hold rating to a strong-buy rating in a research note released on Monday,Zacks.com reports.

A number of other analysts also recently issued reports on PATH. Truist Financial decreased their target price on UiPath from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, September 5th. Evercore ISI boosted their target price on UiPath from $11.00 to $15.00 and gave the company an “in-line” rating in a research note on Friday, May 30th. Needham & Company LLC restated a “hold” rating on shares of UiPath in a research note on Friday, September 5th. Canaccord Genuity Group lowered their target price on UiPath from $16.00 to $15.00 and set a “buy” rating on the stock in a research note on Monday. Finally, Scotiabank boosted their target price on UiPath from $12.00 to $13.00 and gave the company a “sector perform” rating in a research note on Friday, May 30th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, twelve have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $13.18.

Read Our Latest Research Report on PATH

UiPath Trading Down 2.3%

Shares of UiPath stock opened at $11.63 on Monday. The business’s fifty day simple moving average is $11.70 and its 200 day simple moving average is $11.79. The firm has a market capitalization of $6.22 billion, a P/E ratio of 387.50, a price-to-earnings-growth ratio of 4.55 and a beta of 1.02. UiPath has a 12 month low of $9.38 and a 12 month high of $15.93.

UiPath (NYSE:PATHGet Free Report) last issued its quarterly earnings results on Thursday, September 4th. The company reported $0.15 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.07. The business had revenue of $361.73 million for the quarter, compared to analyst estimates of $347.36 million. UiPath had a return on equity of 1.28% and a net margin of 1.35%.UiPath’s quarterly revenue was up 14.6% compared to the same quarter last year. During the same period last year, the company posted $0.04 earnings per share. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. Analysts predict that UiPath will post -0.17 EPS for the current fiscal year.

Insider Activity

In related news, CEO Daniel Dines sold 45,000 shares of the business’s stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $12.01, for a total transaction of $540,450.00. Following the sale, the chief executive officer directly owned 2,700,133 shares in the company, valued at approximately $32,428,597.33. The trade was a 1.64% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In the last 90 days, insiders sold 876,310 shares of company stock worth $10,969,372. Insiders own 23.19% of the company’s stock.

Institutional Trading of UiPath

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. American Trust bought a new stake in shares of UiPath during the 2nd quarter valued at $148,000. Total Investment Management Inc. bought a new stake in shares of UiPath during the 2nd quarter valued at $108,000. Orion Porfolio Solutions LLC raised its stake in shares of UiPath by 12.5% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 28,862 shares of the company’s stock valued at $369,000 after purchasing an additional 3,203 shares during the period. Neuberger Berman Group LLC increased its stake in UiPath by 0.6% in the 2nd quarter. Neuberger Berman Group LLC now owns 2,495,934 shares of the company’s stock worth $31,941,000 after acquiring an additional 13,980 shares during the last quarter. Finally, Marex Group plc bought a new position in UiPath in the 2nd quarter worth about $167,000. 62.50% of the stock is currently owned by institutional investors.

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Stories

Analyst Recommendations for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.